PROPHYLACTIC OKT3, CYA, AND STEROIDS VERSUS ANTILYMPHOBLAST GLOBULIN, CYA, AND STEROIDS IN CADAVERIC KIDNEY-TRANSPLANTATION

被引：0
作者：
GRINO, JM
CASTELAO, AM
SERON, D
GONZALEZ, C
GALCERAN, JM
GILVERNET, S
ANDRES, E
BOVER, J
TORRAS, J
ALSINA, J
机构：
来源：
TRANSPLANTATION PROCEEDINGS | 1992年 / 24卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：39 / 41
页数：3
相关论文
共 50 条
  • [31] BENEFICIAL-EFFECTS OF PROPHYLACTIC OKT3 IN CADAVER KIDNEY-TRANSPLANTATION - COMPARISON WITH CYCLOSPORINE-A IN A SINGLE-CENTER PROSPECTIVE RANDOMIZED STUDY
    GOLDMAN, M
    ABRAMOWICZ, D
    DEPAUW, L
    MARECAUX, G
    VANDERWINDEN, JM
    KINNAERT, P
    VEREERSTRAETEN, P
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (01) : 1046 - 1047
  • [32] PROPHYLACTIC ANTILYMPHOCYTE GLOBULIN AND HLA-DR MATCHING REDUCE THE INCIDENCE OF REJECTION AFTER CADAVERIC KIDNEY-TRANSPLANTATION
    WEIMAR, W
    HENDRIKS, GFJ
    WENTING, GJ
    VINCENT, HH
    SCHREUDER, GMT
    JEEKEL, J
    TRANSPLANTATION PROCEEDINGS, 1987, 19 (05) : 3612 - 3613
  • [33] Treatment of steroid-resistant acute GvHD with OKT3 and high-dose steroids versus high-dose steroids alone.
    Knop, S
    Hebart, H
    Gratwohl, A
    Holler, E
    Apperley, JF
    Kolb, HJ
    Niederwieser, D
    Einsele, H
    BLOOD, 2005, 106 (11) : 45A - 45A
  • [34] THE HIGH FAILURE RATE OF OKT3 IN THE TREATMENT OF ACUTE RENAL-ALLOGRAFT REJECTION RESISTANT TO STEROIDS WITH OR WITHOUT ANTITHYMOCYTE GLOBULIN
    DAVIES, SP
    BROWN, EA
    WOODROW, DF
    PHILLIPS, ME
    GOWER, PE
    MEE, AD
    TRANSPLANTATION, 1991, 52 (04) : 746 - 749
  • [35] THE LONG-TERM EFFECTS OF PROPHYLACTIC OKT3 MONOCLONAL-ANTIBODY IN CADAVER KIDNEY-TRANSPLANTATION - A SINGLE-CENTER, PROSPECTIVE, RANDOMIZED STUDY
    ABRAMOWICZ, D
    GOLDMAN, M
    DEPAUW, L
    VANHERWEGHEM, JL
    KINNAERT, P
    VEREERSTRAETEN, P
    TRANSPLANTATION, 1992, 54 (03) : 433 - 437
  • [36] OKT3 FIRST-LINE TREATMENT OF ACUTE REJECTION EPISODES FOLLOWING COMBINED PANCREAS AND KIDNEY-TRANSPLANTATION
    CANTAROVICH, D
    HOURMANT, M
    DANTAL, J
    GIRAL, M
    PAINEAU, J
    KARAM, G
    SOULILLOU, JP
    TRANSPLANTATION PROCEEDINGS, 1994, 26 (02) : 549 - 549
  • [37] ATGAM versus OKT3 induction therapy in cadaveric kidney transplantation: Patient and graft survival, CD3 subset, infection, and cost analysis
    Kumar, MSA
    Cahill, K
    Kumar, AMS
    Panigrahi, D
    Seirka, D
    Singleton, R
    Al-Abdullah, IH
    Laskow, DA
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (04) : 1351 - 1352
  • [38] PILOT-STUDY ON INDUCTION TREATMENT WITH HIGH-DOSE OKT3 - PRELIMINARY-OBSERVATIONS IN KIDNEY-TRANSPLANTATION
    WELTER, HF
    ILNER, WD
    SCHLEIBNER, S
    ABENDROTH, D
    HANCKE, E
    GROH, J
    LAND, W
    TRANSPLANTATION PROCEEDINGS, 1990, 22 (05) : 2272 - 2272
  • [39] CYCLOSPORIN-A (CY-A) THERAPY WITH OR WITHOUT STEROIDS IN CADAVERIC KIDNEY-TRANSPLANTATION - A PROSPECTIVE RANDOMIZED ONE-CENTER STUDY
    ALBERT, FW
    SCHMIDT, U
    KIDNEY INTERNATIONAL, 1985, 28 (04) : 708 - 708
  • [40] OPTIMAL RESULTS IN CADAVERIC RENAL-TRANSPLANTATION WITH LOW-DOSE CYCLOSPORINE AND STEROIDS COMBINED WITH PROPHYLACTIC ANTI-LYMPHOCYTE GLOBULIN
    FRIES, D
    HIESSE, C
    CHARPENTIER, B
    CANTAROVICH, M
    LANTZ, O
    BENOIT, G
    TRANSPLANTATION PROCEEDINGS, 1988, 20 (05) : 23 - 25
12345